Pfizer Inc. (NYSE:PFE) enjoyed a rare lift in its stock on Tuesday after releasing data which showed positive results in the phase II study of oncology drug candidate palbociclib. Pfizer Inc. (NYSE:PFE) stock opened today at $30.99 and is currently trading at $30.81. The stock showed a positive weekly performance of 3.35%.
Boston Scientific Corporation (NYSE:BSX) reported robust Q4 results, beating market expectations with all of its divisions contributing to the turnaround. During the quarter, the Cardiac Rhythm Management (CRM) division, contributing about 25% to the company’s top line, reported 3% sales growth year-over-year (y-o-y) on a constant currency basis. Boston Scientific Corporation (NYSE:BSX) stock opened at $12.77, in current trading session and currently is at $12.66, by losing -1.44%. The 52 week range of $7.07 – $14.08. Company’s market capitalization is $16.91billion.
Merck & Co., Inc. (NYSE:MRK) reported a fiscal fourth-quarter profit of $781 million, or 26 cents a share, compared with earnings of $908 million, or 30 cents a share, a year ago. Merck & Co., Inc. (NYSE:MRK) stock is currently trading at $53.92. The EPS of the stock is 1.51. Company’s market capitalization is $157.80billion.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened the session at $7.02, and now is at $7.23. The 52 week range of the ARIA stock remained $2.15 – $23.00 and the day range was $7.02 – $7.31.